Delivery Order SPE2DB22D3004-SPE2DB24FPL74
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,299.44 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any special designation....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Clindamycin Phosphate 1% Foam, a prescription medication, to the Defense Logistics Agency (DLA). The contract, valued at $2,783.28, is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $1,130.90 firm-fixed-price delivery order contract has a completion date of May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560408677 - Clindamycin Phosphate 1% Foam 50GM, with a ceiling value of $2,433.39 and a completion date of March 29, 2023. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This is a $1,354.58 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,166,349 units of Clindamycin Phosphate 1% Foam, a prescription pharmaceutical product. The order has a completion date of July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to provide a wide range of medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clindamycin Phosphate 1% Foam in 100-gram units, with a ceiling value of $1,208.38. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $6,252.08 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic pharmaceutical product. The contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance of work also...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $1,437.66, is for the supply of 4563957329 - CLINDAMYCIN PHOSPHATE 1% FOAM 100GM. The contract has a period of performance ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.66 Delivery Order contract is for the supply of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of November 7, 2024. The contract has a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,637.46, is for the delivery of Clindamycin Phosphate 1% Foam, 50GM. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of December 26, 2024. The contract is not designated as a set-aside and represents an open competition award....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPL74Delivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract valued at $2,692.77 for the provision of 4563787496 - Clindamycin Phosphate 1% Foam, 50GM. This delivery order contract has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this contract, which does not have a set-aside designation. The company also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/27/24 |